Novavax Shares Are Trading Higher on Continued Strength. The Company Last Week Announced a Co-exclusive Licensing Agreement With Sanofi to Commercialize a COVID-19 Vaccine and Develop COVID-influenza Combination Vaccines.
Novavax Shares Are Trading Higher on Continued Strength. The Company Last Week Announced a Co-exclusive Licensing Agreement With Sanofi to Commercialize a COVID-19 Vaccine and Develop COVID-influenza Combination Vaccines.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.